MedTrace Logo

Clinical Study of Methylene Blue - Mediated Photodynamic Therapy for Diabetic Lower Limb Ulcer

NCT03222544 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-04-23

No results posted yet for this study

Summary

The investigators designed this prospective, randomized control study to confirm the efficacy and safety of methylene blue - mediated photodynamic therapy for diabetic lower limb ulcer and to explore its mechanism.

Conditions

  • Diabetic Extremity Lower Ulcers

Interventions

COMBINATION_PRODUCT

methylene blue

Continue treatment after 5mins suspension if the patient feels that the local temperature is too high to stand

COMBINATION_PRODUCT

Photon therapy instrument

Continue treatment after 5mins suspension if the patient feels that the local temperature is too high to stand

Sponsors & Collaborators

  • Chongqing Medical University

    lead OTHER

Principal Investigators

  • Qingfeng Cheng, PhD · the First Affiliated Hospital, Chongqing Medical University, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-29
Primary Completion
2020-04-29
Completion
2020-06-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03222544 on ClinicalTrials.gov